Vendor profile
Research · US · —
Shandong Aishi Biotechnology
B+
Composite 8.3 / 10
Last updated 2026-10-05. Composite is computed from the live database; missing sub-scores redistribute weight across the others.
Peptide breakdown
| Peptide | Score | Lab quality | Tests | Purity | Qty var. | $/mg verified | Last test | Ranking |
|---|---|---|---|---|---|---|---|---|
| GHK-Cu | 9.6A |
9.5 | 16 | — | — | — | — | view |
| Tirzepatide | 8.4B+ |
8.0 | 30 | — | — | — | — | view |
| Retatrutide | 8.3B+ |
7.9 | 25 | — | — | — | — | view |
| Ipamorelin | 7.4B |
7.5 | 4 | — | — | — | — | view |
| Tesamorelin | 5.8C |
4.8 | 6 | — | — | — | — | view |
| BPC-157 | 5.5C |
5.5 | 3 | — | — | — | — | view |
| MOTS-c | — |
— | 0 | — | — | — | — | view |
| Semaglutide | — |
— | 0 | — | — | — | — | view |
COA transparency
- ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
- ○ Both HPLC and mass spec shown (pending)
- ○ Endotoxin or sterility data shown (pending)
- ○ At least one COA independently cross-checked (pending)
- ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Shandong Aishi Biotechnology against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.